Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 1 | $101,368 |
| Sells | 10 | $3,122,757 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 16 Sep 2024 17:30 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 12 Sep 2024 | Purchase | 40,000 | 2.5342 | 101,368 | D |
| 07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 05 Mar 2024 | Sale | 1,792 | 18.7279 | 33,560 | D |
| 11 Jan 2024 17:11 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 09 Jan 2024 | Sale | 2,716 | 16.3281 | 44,347 | D |
| 18 May 2023 20:54 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 May 2023 | Sale | 500 | 27.6 | 13,800 | D |
| 18 May 2023 20:54 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 May 2023 | Sale | 32,000 | 26.9266 | 861,651 | D |
| 24 Mar 2023 18:48 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 Mar 2023 | Sale A | 1,704 | 32.4649 | 55,320 | D |
| 24 Mar 2023 18:48 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 Mar 2023 | Sale A | 30,796 | 31.8593 | 981,139 | D |
| 20 Mar 2023 20:18 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 Mar 2023 | Sale | 1,704 | 32.4649 | 55,320 | D |
| 20 Mar 2023 20:18 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 Mar 2023 | Sale | 30,796 | 31.8593 | 981,139 | D |
| 10 Jan 2023 19:20 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 06 Jan 2023 | Sale | 822 | 36.7888 | 30,240 | D |
| 10 Jan 2023 19:20 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 06 Jan 2023 | Sale | 1,836 | 36.0789 | 66,241 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)